Research Article

Research on the Targeted Treatment of Squamous Cell Carcinoma by Nanographene Drug Delivery System

Figure 9

HE staining of major organs of mice in different treatment groups after treatment group. (a) Control group (200 μg/saline solution, heart, liver, kidneys, ×200); (b) experimental group (200 μg/CDDP, heart, liver, kidneys, ×200); (c) experimental group (200 μg/graphene carrier complex, heart, liver, kidney, ×200).
(a)
(b)
(c)